BioNxt Solutions Inc. (OTCMKTS:BNXTF – Get Free Report) was the target of a large decrease in short interest during the month of July. As of July 31st, there was short interest totaling 1,000 shares, a decrease of 99.2% from the July 15th total of 132,765 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily trading volume, of 484 shares, the days-to-cover ratio is presently 2.1 days.
BioNxt Solutions Price Performance
OTCMKTS:BNXTF traded up $0.01 during trading hours on Tuesday, hitting $0.23. 200 shares of the company traded hands, compared to its average volume of 222. The firm’s 50-day simple moving average is $0.25 and its 200-day simple moving average is $0.34. BioNxt Solutions has a one year low of $0.14 and a one year high of $0.80.
BioNxt Solutions (OTCMKTS:BNXTF – Get Free Report) last posted its earnings results on Friday, May 29th. The company reported ($0.01) earnings per share (EPS) for the quarter.
BioNxt Solutions Company Profile
BioNxt Solutions Inc (OTCMKTS:BNXTF) is a life sciences company specializing in advanced proteomics, metabolomics and bioinformatics solutions. The company’s platform combines state-of-the-art mass spectrometry and chromatography workflows with cloud-based data analysis tools, enabling high-throughput characterization of proteins, metabolites and other biomolecules for research and development purposes.
BioNxt Solutions offers contract research services to clients in the pharmaceutical, biotechnology and academic sectors, providing end-to-end support from sample preparation through to data interpretation.
See Also
- Five stocks we like better than BioNxt Solutions
- Atlassian Just Pulled Off the Software Comeback Wall Street Wanted
- AST SpaceMobile Earnings Just Reminded Investors How Risky Space Can Be
- NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
- Apple’s Next iPhone Could Test How Much Pricing Power Is Left
Receive News & Ratings for BioNxt Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNxt Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
